Transamerica Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.82M | Buy |
14,368
+1,492
| +12% | +$197K | 0.15% | 148 |
|
|
2026
Q1 | $1.79M | Buy |
12,876
+48
| +0.4% | +$6.72K | 0.15% | 137 |
|
|
2025
Q4 | $1.57M | Sell |
12,828
-168
| -1% | -$20.4K | 0.13% | 149 |
|
|
2025
Q3 | $1.44M | Buy |
12,996
+336
| +3% | +$38.2K | 0.12% | 129 |
|
|
2025
Q2 | $1.4M | Sell |
12,660
-399
| -3% | -$42.5K | 0.13% | 122 |
|
|
2025
Q1 | $1.46M | Sell |
13,059
-2,101
| -14% | -$217K | 0.15% | 129 |
|
|
2024
Q4 | $1.4M | Sell |
15,160
-1,685
| -10% | -$152K | 0.14% | 125 |
|
|
2024
Q3 | $1.41M | Sell |
16,845
-235
| -1% | -$17.9K | 0.14% | 127 |
|
|
2024
Q2 | $1.17M | Hold |
17,080
| – | – | 0.13% | 123 |
|
|
2024
Q1 | $1.25M | Sell |
17,080
-7,292
| -30% | -$561K | 0.13% | 133 |
|
|
2023
Q4 | $1.98M | Sell |
24,372
-6,103
| -20% | -$475K | 0.27% | 55 |
|
|
2023
Q3 | $2.28M | Sell |
30,475
-2,084
| -6% | -$160K | 0.31% | 54 |
|
|
2023
Q2 | $2.51M | Buy |
32,559
+644
| +2% | +$51.4K | 0.33% | 53 |
|
|
2023
Q1 | $2.65M | Buy |
31,915
+858
| +3% | +$71.1K | 0.35% | 52 |
|
|
2022
Q4 | $2.67M | Sell |
31,057
-2,648
| -8% | -$210K | 0.38% | 47 |
|
|
2022
Q3 | $2.08M | Buy |
33,705
+3,087
| +10% | +$195K | 0.31% | 58 |
|
|
2022
Q2 | $1.89M | Buy |
30,618
+30,607
| +278,245% | +$1.89M | 0.27% | 58 |
|
|
2022
Q1 | $1K | Hold |
11
| – | – | 0.04% | 75 |
|
|
2021
Q4 | $1K | Hold |
11
| – | – | 0.03% | 84 |
|
|
2021
Q3 | $1K | Hold |
11
| – | – | 0.03% | 83 |
|
|
2021
Q2 | $1K | Hold |
11
| – | – | 0.02% | 130 |
|
|
2021
Q1 | $1K | Hold |
11
| – | – | 0.02% | 149 |
|
|
2020
Q4 | $1K | Sell |
11
-5
| -31% | -$302 | 0.02% | 140 |
|
|
2020
Q3 | $1K | Sell |
16
-25,158
| -100% | -$1.74M | 0.02% | 156 |
|
|
2020
Q2 | $1.94M | Buy |
+25,174
| New | +$1.93M | 0.42% | 49 |
|
|
2019
Q3 | – | Sell |
-328
| Closed | -$23K | – | 256 |
|
|
2019
Q2 | $23K | Buy |
+328
| New | +$21.6K | 0.01% | 272 |
|
|
2019
Q1 | – | Sell |
-448
| Closed | -$28K | – | 229 |
|
|
2018
Q4 | $28K | Buy |
448
+41
| +10% | +$2.87K | 0.01% | 254 |
|
|
2018
Q3 | $32K | Buy |
407
+389
| +2,161% | +$29.4K | 0.01% | 251 |
|
|
2018
Q2 | $2K | Sell |
18
-42
| -70% | -$2.97K | ﹤0.01% | 316 |
|
|
2018
Q1 | $5K | Sell |
60
-30
| -33% | -$2.38K | ﹤0.01% | 290 |
|
|
2017
Q4 | $7K | Sell |
90
-108
| -55% | -$8.2K | ﹤0.01% | 275 |
|
|
2017
Q3 | $16K | Sell |
198
-15
| -7% | -$1.15K | ﹤0.01% | 261 |
|
|
2017
Q2 | $16K | Sell |
213
-59,791
| -100% | -$3.98M | ﹤0.01% | 242 |
|
|
2017
Q1 | $4.08M | Sell |
60,004
-290
| -0.5% | -$20.4K | 0.49% | 66 |
|
|
2016
Q4 | $4.32M | Buy |
60,294
+1,690
| +3% | +$126K | 0.51% | 66 |
|
|
2016
Q3 | $4.64M | Buy |
58,604
+5,303
| +10% | +$431K | 0.5% | 62 |
|
|
2016
Q2 | $4.45M | Sell |
53,301
-848
| -2% | -$75.3K | 0.45% | 61 |
|
|
2016
Q1 | $4.97M | Buy |
54,149
+50,065
| +1,226% | +$4.51M | 0.42% | 57 |
|
|
2015
Q4 | $414K | Buy |
4,084
+208
| +5% | +$21.6K | 0.03% | 254 |
|
|
2015
Q3 | $381K | Sell |
3,876
-312
| -7% | -$34.7K | 0.03% | 236 |
|
|
2015
Q2 | $491K | Buy |
4,188
+3,525
| +532% | +$385K | 0.04% | 228 |
|
|
2015
Q1 | $66K | Sell |
663
-3,120
| -82% | -$317K | ﹤0.01% | 405 |
|
|
2014
Q4 | $357K | Buy |
3,783
+1,248
| +49% | +$129K | 0.03% | 233 |
|
|
2014
Q3 | $270K | Sell |
2,535
-385
| -13% | -$37.7K | 0.02% | 234 |
|
|
2014
Q2 | $244K | Buy |
2,920
+2,720
| +1,360% | +$212K | 0.02% | 258 |
|
|
2014
Q1 | $15K | Sell |
200
-9,808
| -98% | -$769K | ﹤0.01% | 433 |
|
|
2013
Q4 | $752K | Buy |
10,008
+2,533
| +34% | +$176K | 0.08% | 122 |
|
|
2013
Q3 | $470K | Sell |
7,475
-1,317
| -15% | -$78.7K | 0.06% | 145 |
|
|
2013
Q2 | $451K | Buy |
+8,792
| New | +$458K | 0.07% | 122 |
|
Other funds holding GILD
Transamerica Financial Advisors's GILD Position: Q2 2026 in Review
Transamerica Financial Advisors increased its Gilead Sciences (GILD) stake by 12% in Q2 2026, buying an estimated $197K and bringing the position to 14,368 shares worth $1.82M. The position accounts for 0.15% of the portfolio, ranked #148.
Transamerica Financial Advisors first reported a position in GILD in Q2 2013 and has held it in 49 quarters since. The position peaked at $4.97M in Q1 2016. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Transamerica Financial Advisors held 14,368 shares of Gilead Sciences worth $1.82M as of Q2 2026.
- Transamerica Financial Advisors bought 1,492 Gilead Sciences shares in Q2 2026, an estimated $197K.
- Gilead Sciences made up 0.15% of Transamerica Financial Advisors's portfolio in Q2 2026, its #148 holding.
- Transamerica Financial Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 49 quarters since.
- Transamerica Financial Advisors's Gilead Sciences position peaked at $4.97M in Q1 2016.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.